Impact of Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain in the Setting of Endoscopic Sinonasal Surgery.

Trial Profile

Impact of Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain in the Setting of Endoscopic Sinonasal Surgery.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Ropivacaine (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms ROPI-POSTOP
  • Most Recent Events

    • 03 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2019.
    • 03 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2019.
    • 13 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top